# Medrio

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Medrio provides an Electronic Data Capture (EDC) platform designed for small and scaling clinical teams, offering enterprise-grade rigor with no-code agility. It delivers an all-in-one integrated suite including EDC/CDMS, ePRO/eCOA, eConsent, and RTSM, complemented by expert clinical trial project management and data services.

- Business Profile: https://optimly.ai/brand/medrio
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://medrio.com/
- Logo: https://logo.clearbit.com/medrio.com
- Slug: medrio
- Brand Authority Index tier: Emerging
- Archetype: Challenger
- Category: Clinical Trial Technology
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Paper-based clinical data collection: Utilizing traditional paper forms for data collection and manual data entry, leading to slower processes, higher error rates, and increased labor. | External CRO for data management: Outsourcing all data management, biostatistics, and project management tasks to a Contract Research Organization (CRO) rather than using an in-house platform with sup | Continue with inefficient existing systems: Persisting with existing, potentially outdated, overly complex, or lightweight clinical data management systems that hinder agility, scalability, and data q
Solutions: Medrio EDC | no-code clinical trial software | eClinical solutions for CROs | Disparate specialized clinical trial software: Using separate, non-integrated software solutions for EDC, ePRO, eConsent, and RTSM, leading to data silos, integration challenges, and workflow ineffici
---
## Full Details / RAG Data
### Overview
Medrio has a Business Profile in the Optimly AI Brand Index.
Medrio provides an Electronic Data Capture (EDC) platform designed for small and scaling clinical teams, offering enterprise-grade rigor with no-code agility. It delivers an all-in-one integrated suite including EDC/CDMS, ePRO/eCOA, eConsent, and RTSM, complemented by expert clinical trial project management and data services.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Medrio |
| Slug         | medrio |
| URL          | https://optimly.ai/brand/medrio |
| Logo         | https://logo.clearbit.com/medrio.com |
| Brand Authority Index tier | Emerging |
| Archetype    | Challenger |
| Category     | Clinical Trial Technology |
| Last Analyzed | August 9, 2026 |
| Last Updated | 2026-08-13T10:27:49.641Z |
### Verified Facts
- Founded: 2005
- Headquarters: San Francisco, CA
### Buyer Intent Signals
#### Problems this brand solves
- Paper-based clinical data collection: Utilizing traditional paper forms for data collection and manual data entry, leading to slower processes, higher error rates, and increased labor.
- External CRO for data management: Outsourcing all data management, biostatistics, and project management tasks to a Contract Research Organization (CRO) rather than using an in-house platform with sup
- Continue with inefficient existing systems: Persisting with existing, potentially outdated, overly complex, or lightweight clinical data management systems that hinder agility, scalability, and data q
#### Buyers search for
- Medrio EDC
- no-code clinical trial software
- eClinical solutions for CROs
- Disparate specialized clinical trial software: Using separate, non-integrated software solutions for EDC, ePRO, eConsent, and RTSM, leading to data silos, integration challenges, and workflow ineffici
### Links
- Canonical page: https://optimly.ai/brand/medrio
- Official website: https://medrio.com/
- Publisher: https://optimly.ai
- Dataset: https://optimly.ai/brand
- JSON endpoint: /brand/medrio.json
- LLMs.txt: /brand/medrio/llms.txt